COVID-19 AstraZeneca issues: Pfizer, Moderna are ‘preferred’ for second shot, U.S. travel problem may arise
Published
National Advisory Committee on Immunization (NACI) is now recommending that individuals who received a single dose of the AstraZeneca...
Full Article